AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS

Health Issues HCR

Labor-Health and Human Services Appropriations seeking Food and Drug Administration funding.

Contacted: Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Drug Enforcement Administration (DEA); SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Communication with Centers for Medicare and Medicaid Services regarding Innovation Center and direct reimbursement under Medicare Program.

Contacted: SENATE; Government Accountability Office (GAO); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA)

Pharmacy PHA

Contact concerning FDA authority to manage drug shortages, and regulation of pharmacy compounding. Contact concerning HRSA oversight of 340B drug discount program. Communication to DEA on central fill of controlled substances. Contact concerning S. 959, Pharmaceutical Compounding and Quality and Accountability Act, (all sections) to address FDA oversight of certain drug compounding entities. Contact concerning S. 957, Drug Supply Chain Security Act, (all sections) to track and trace drug products.

Contacted: Centers For Medicare and Medicaid Services (CMS); Drug Enforcement Administration (DEA); SENATE; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES

Bills named: S. 957 (113th), S. 959 (113th)